166 related articles for article (PubMed ID: 23944651)
1. Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions.
Hamzeh-Cognasse H; Damien P; Nguyen KA; Arthaud CA; Eyraud MA; Chavarin P; Absi L; Osselaer JC; Pozzetto B; Cognasse F; Garraud O
Transfusion; 2014 Mar; 54(3):613-25. PubMed ID: 23944651
[TBL] [Abstract][Full Text] [Related]
2. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions.
Blumberg N; Gettings KF; Turner C; Heal JM; Phipps RP
Transfusion; 2006 Oct; 46(10):1813-21. PubMed ID: 17002639
[TBL] [Abstract][Full Text] [Related]
3. Removal by adsorbent beads of biological response modifiers released from platelets, accumulated during storage, and potentially associated with platelet transfusion reactions.
Tanaka S; Hayashi T; Tani Y; Hirayama F
Transfusion; 2010 May; 50(5):1096-105. PubMed ID: 20051054
[TBL] [Abstract][Full Text] [Related]
4. Release of potential immunomodulatory factors during platelet storage.
Cognasse F; Boussoulade F; Chavarin P; Acquart S; Fabrigli P; Lamy B; Garraud O
Transfusion; 2006 Jul; 46(7):1184-9. PubMed ID: 16836566
[TBL] [Abstract][Full Text] [Related]
5. Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers.
Cognasse F; Aloui C; Anh Nguyen K; Hamzeh-Cognasse H; Fagan J; Arthaud CA; Eyraud MA; Sebban M; Fromont E; Pozzetto B; Laradi S; Garraud O
Transfusion; 2016 Feb; 56(2):497-504. PubMed ID: 26446055
[TBL] [Abstract][Full Text] [Related]
6. Amotosalen-HCl-UVA pathogen reduction does not alter poststorage metabolism of soluble CD40 ligand, Ox40 ligand and interkeukin-27, the cytokines that generally associate with serious adverse events.
Hamzeh-Cognasse H; Laradi S; Osselaer JC; Cognasse F; Garraud O
Vox Sang; 2015 Feb; 108(2):205-7. PubMed ID: 25334045
[TBL] [Abstract][Full Text] [Related]
7. Removal of biological response modifiers associated with platelet transfusion reactions by columns containing adsorption beads.
Tanaka S; Hayashi T; Tani Y; Hirayama F
Transfusion; 2014 Jul; 54(7):1790-7. PubMed ID: 24417744
[TBL] [Abstract][Full Text] [Related]
8. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
Skripchenko A; Kurtz J; Moroff G; Wagner SJ
Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
[TBL] [Abstract][Full Text] [Related]
9. Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment.
Cognasse F; Osselaer JC; Payrat JM; Chavarin P; Corash L; Garraud O
Transfusion; 2008 May; 48(5):809-13. PubMed ID: 18298593
[TBL] [Abstract][Full Text] [Related]
10. Platelet transfusion alters CD40L blood level and release capacity in patients suffering from thrombocytopenia.
Wenzel F; Günther W; Baertl A; Gruber W; Sorg RV; Haas R; Giers G
Transfusion; 2012 Jun; 52(6):1213-20. PubMed ID: 22082313
[TBL] [Abstract][Full Text] [Related]
11. Incidence of acute transfusion reactions to platelets in hospitalized pediatric patients based on the US hemovigilance reporting system.
Li N; Williams L; Zhou Z; Wu Y
Transfusion; 2014 Jun; 54(6):1666-72. PubMed ID: 24410992
[TBL] [Abstract][Full Text] [Related]
12. Differential protein expression of blood platelet components associated with adverse transfusion reactions.
Aloui C; Barlier C; Claverol S; Fagan J; Awounou D; Tavernier E; Guyotat D; Hamzeh-Cognasse H; Cognasse F; Garraud O; Laradi S
J Proteomics; 2019 Mar; 194():25-36. PubMed ID: 30590131
[TBL] [Abstract][Full Text] [Related]
13. Pathogen reduction treatment alters the immunomodulatory capacity of buffy coat-derived platelet concentrates.
Loh YS; Johnson L; Kwok M; Marks DC
Transfusion; 2014 Mar; 54(3):577-84. PubMed ID: 23829895
[TBL] [Abstract][Full Text] [Related]
14. Level of platelet-derived cytokines in leukoreduced red blood cells is influenced by the processing method and type of leukoreduction filter.
Glenister KM; Sparrow RL
Transfusion; 2010 Jan; 50(1):185-9. PubMed ID: 19694993
[TBL] [Abstract][Full Text] [Related]
15. The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst.
Xie RF; Hu P; Li W; Ren YN; Yang J; Yang YM; Wang ZY; Fan HH
Vox Sang; 2014 Apr; 106(3):234-41. PubMed ID: 24138005
[TBL] [Abstract][Full Text] [Related]
16. Replaced platelet concentrates containing a new additive solution, M-sol: safety and efficacy for pediatric patients.
Yanagisawa R; Shimodaira S; Kojima S; Nakasone N; Ishikawa S; Momose K; Honda T; Yoshikawa K; Saito S; Tanaka M; Nakazawa Y; Sakashita K; Shiohara M; Akino M; Hirayama J; Azuma H; Koike K
Transfusion; 2013 Sep; 53(9):2053-60. PubMed ID: 23252617
[TBL] [Abstract][Full Text] [Related]
17. Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions.
Savage WJ; Savage JH; Tobian AA; Thoburn C; Hamilton RG; Schroeder JT; Ness PM
Transfusion; 2012 Mar; 52(3):575-81. PubMed ID: 21883267
[TBL] [Abstract][Full Text] [Related]
18. A computerized prediction model of hazardous inflammatory platelet transfusion outcomes.
Nguyen KA; Hamzeh-Cognasse H; Sebban M; Fromont E; Chavarin P; Absi L; Pozzetto B; Cognasse F; Garraud O
PLoS One; 2014; 9(5):e97082. PubMed ID: 24830754
[TBL] [Abstract][Full Text] [Related]
19. Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion.
Kaufman J; Spinelli SL; Schultz E; Blumberg N; Phipps RP
J Thromb Haemost; 2007 Apr; 5(4):788-96. PubMed ID: 17403203
[TBL] [Abstract][Full Text] [Related]
20. An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment.
Osselaer JC; Cazenave JP; Lambermont M; Garraud O; Hidajat M; Barbolla L; Tardivel R; Defoin L; Waller C; Mendel I; Raidot JP; Kandel G; De Meuter R; Fabrigli P; Dehenau D; Arroyo JL; Padrón F; Gouezec H; Corral M; Jacquet M; Sundin D; Lin L; Corash L
Vox Sang; 2008 May; 94(4):315-23. PubMed ID: 18248574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
